Conversations in Healthcare
By Clarivate
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Clarivate
Category: Business News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 48
Description
Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
Lighting the touch paper for next generation nucleic acid therapies
|
May 03, 2023 |
|
Realizing the patient-friendly future of clinical trials
|
Jul 05, 2022 |
|
How Patient Connect addresses unmet needs at the point of care
|
Apr 18, 2022 |
|
Social determinants: barriers to healthcare impacting racial and ethnic minorities
|
Feb 10, 2022 |
|
How Novo Ventures prioritized their investment strategy during the pandemic
|
Dec 13, 2021 |
|
How Healx uses AI to transform rare disease drug discovery
|
Dec 01, 2021 |
|
How the pandemic shifted Roche’s priorities and R&D investments
|
Nov 15, 2021 |
|
Optimizing patient-first clinical trials with advanced site intelligence
|
Nov 02, 2021 |
|
Showing the value of regulatory intelligence in pharma
|
Oct 11, 2021 |
|
Overcoming health inequity in the U.S. and the role of telehealth: Ideas and best practices from Cigna, Henry Ford Health System and the eHealth Initiative
|
Sep 21, 2021 |
|
Best practices for university - healthcare partnerships: Learnings from the Institute of Cancer Research
|
Aug 19, 2021 |
|
Best practices for university – healthcare partnerships: Learnings from Oxford
|
Jul 31, 2021 |
|
The evolution of the asset-centric approach in biotech venture capital
|
Jun 11, 2021 |
|
Drugs to Watch 2021
|
Jun 03, 2021 |
|
The past, present and future of next generation sequencing
|
Dec 02, 2020 |
|
Early planning key to successful access and product launch
|
Dec 02, 2020 |
|
Transforming the treatment of cancer with oncolytic viruses
|
Dec 02, 2020 |
|
COVID-19, multi-stem clinical trials and a new way of fundraising
|
Dec 02, 2020 |
|
Possible treatment for COVID-19 related respiratory failure
|
Dec 02, 2020 |
|
Utilizing pluripotent stem cells in cell therapy
|
Dec 02, 2020 |
|
Pivoting a product launch during the pandemic
|
Dec 02, 2020 |
|
A novel approach to treating neurodegenerative disease
|
Dec 02, 2020 |
|
How Glympse Bio oversubscribed their Series B funding amidst the pandemic
|
Dec 02, 2020 |
|
An update from biopharma’s hotspot
|
Dec 02, 2020 |
|
Securing investments amidst COVID-19 and Brexit uncertainties
|
Nov 18, 2020 |
|
The advantages of onsite manufacturing facilities for clinical trials
|
Nov 18, 2020 |
|
How including patients can help with the fight against Parkinson’s Disease
|
Nov 18, 2020 |
|
Collaborating with officials to continue developments
|
Nov 18, 2020 |
|
An unprecedented time of scientific innovation
|
Nov 18, 2020 |
|
Addressing strategic challenges for biotech companies
|
Nov 18, 2020 |
|
Bringing together minds to combat COVID-19
|
Nov 18, 2020 |
|
Maximising R+D efforts through better epidemiology understanding
|
Nov 18, 2020 |
|
Bringing new medicines to market despite subjective endpoints
|
Nov 18, 2020 |
|
How COVID is reshaping global policy and what it means for market access
|
Nov 18, 2020 |
|
Revolutionising the neurodegenerative space – fundraising, development & beyond
|
Nov 18, 2020 |
|
The pandemic, politicians and science
|
Nov 17, 2020 |
|
Will healthcare change after COVID-19?
|
Nov 17, 2020 |
|
How China has grown through innovation to rival the US market
|
Nov 17, 2020 |
|
How innovation can continue to evolve and shape the pharma space
|
Nov 17, 2020 |
|
Becoming one of the leaders in developing COVID-19 diagnostics
|
Nov 17, 2020 |
|
Using a problem centric approach to build programs
|
Nov 17, 2020 |
|
The effects of COVID-19 on worldwide oncology clinical trials
|
Nov 17, 2020 |
|
COVID-19 continues to disrupt patient care
|
Nov 17, 2020 |
|
To know COVID-19 is to know medicine
|
Nov 14, 2020 |
|
Impact of COVID-19 on the development of CAR T-cell therapies
|
Nov 13, 2020 |
|
Wuhan experience shapes the new normal for healthcare
|
Nov 13, 2020 |
|
Creating a collaborative toolbox to fight COVID-19
|
Nov 13, 2020 |
|
Pivoting a product launch during the pandemic
|
Oct 02, 2020 |